Si está buscando comprar medicamentos en línea en España, es importante elegir una farmacia en línea de confianza y segura para garantizar que los medicamentos que reciba sean auténticos y de alta calidad. En comprar-farmacia.es, ofrecemos una amplia selección de medicamentos, incluido Cialis para la disfunción eréctil (DE), y trabajamos con farmacias acreditadas para garantizar la calidad y la autenticidad de nuestros productos.
Visite nuestro sitio web en comprar-farmacia.es para obtener más información sobre nuestros productos y servicios. Nuestro equipo de atención al cliente está disponible para ayudarlo en todo momento y garantizar una experiencia de compra en línea segura y satisfactoria.
Vinay raja, m
VINAY RAJA, M.D. CURRICULUM VITAE PROFESSIONAL DESIGNATION
Licensed to Practice Medicine: Hawaii
Board Certifications:
Additional Credentials:
Home Health Care Examination - Attested by the Institute for
EDUCATIONAL BACKGROUND
The University of Texas Medical Branch at Galveston
Fellowship in Medical Oncology
John A. Burns School of Medicine, University of Hawaii.
(John A. Hartford Foundation Center of Excellence in Geriatrics)
Fellowship in Geriatric Medicine July
Mount Sinai School of Medicine/Jersey City Medical Center
Chief Medical Resident, Internal Medicine July Residency in Internal Medicine July Rotating Internship Bachelor of Medicine/Bachelor of Surgery (MBBS) Aug. 1988-Feb. 1993 VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 2 Pre-Medical Education
Physics, Chemistry, Mathematics and Biology
PROFESSIONAL EXPERIENCE PROFESSIONAL APPOINTMENTS
Phelps County Regional Medical Center, Cancer Registry Data
Quality Assurance Coordinator PROFESSIONAL AND BOARD AFFILIATIONS HOSPITAL AFFILIATIONS PUBLICATIONS AND ABSTRACTS
Boccia R, Malik IA, Raja V, Kahanic S, Liu R, Lillie T, Tomita S, Clowney B, Silberstein P. Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia. Oncologist. 2006 Apr;11(4):409-17. April 2006 Raja V, Balakrishnan R, Bollinger W, Crabtree D, Downey E, Mohindra M: Double Diagnosis in Cancer Patients and Cutaneous Reaction Related to Gemcitabine: CASE 2. Mixed Carcinoid-Adenocarcinoma of the Appendix. J Clinical Oncology. 2005 Oct. 1; 23(28):7223-4. October 2005 VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 3
Raja V, Bryant B, Bessman DJ, Alperin JB: Soft Tissue Sarcomas: CASE 1. Granulocytic Sarcoma: Presentation With Nodal and Skin Involvement: J Clin Oncology. 2004 May 15;22(10):2026-7. May 2004 Raja V, Campbell GA: Unusual Cases Involving the CNS and Nasal Sinuses: CASE 2. SINONASAL UNDIFFERENTIATED CARCINOMA: J Clin Oncol. 2003 Oct: 3877-3880. October 2003 Raja V, Bessman D: Uncommon Presentations of Malignancies: CASE 4. TUMOR IMPLANTATION AFTER PNEUMONECTOMY FOR LUNG CANCER: J Clin Oncol. 2003 Aug 1; 21(15): 2998-9. August 2003 Boroumand N, Raja V, Jones DV, Haque AK:SYT-SSX2 variant of primary pulmonary synovial sarcoma with focal expression of CD117 (c-Kit) protein and a poor clinical outcome. Arch Pathol Lab Med. 2003 April;127(4):e201-4. April 2003 Raja V, Lin JT, Xiao SY: Unusual Abdominal Tumors: CASE 2. INTRA- ABDOMINAL DESMOPLASTIC SMALL ROUND CELL TUMOR. J Clin Oncol. 2003 Mar 1;21(5):951-953. March 2003 Raja V, Montoya M: INTRAMEDULLARY SPINAL CORD METASTASIS FROM MELANOMA: A CASE REPORT AND REVIEW OF LITERATURE. Manuscript submitted to Oncology Spectrums for review. January 2003 Coinvestigator- “ A Prospective Open Label Study of Methyphenidate (Ritalin) for Treatment of Fatigue in Patients with Cancer” - Ongoing Study. University of Texas Medical Branch at Galveston. September 2002 Raja V, China C, Masaki KH, Nakano G: Unusual presentations of uncommon tumors: Case 1. Benign metastasizing pleomorphic adenoma. J Clin Oncol 2002 May 1;20(9):2400-2403. May 2002 Presented at the February 9-10, 2001 Hawaii Chapter Annual Scientific Meeting of the American College of Physicians - American Society of Internal Medicine, Poster Session, Honolulu, Hawaii. Subinvestigator: A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Three Fixed Doses of Aripiprazole in the Treatment of Institutionalized Patients with Psychosis Associated with Dementia of the Alzheimer’s Type. Bristol-Myers. January 2001-June 2001 VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 4
Squibb Research – Univ of Hawaii, Kuakini Medical Center, 347 N. Kuakini St. HPM-9, Honolulu, HI 96817. V. Raja, W.F. Wong, K.H. Masaki. Causes of Death in Patients with Dementia. Abstract published in Journal of the American Geriatrics Society, April 2001;49:S116.
Presented at the May 9, 2001 John A. Hartford Foundation Center and the American Federation for Aging Research (AFAR) Fellows Poster Session in Chicago, Illinois.
Presented at the February 9-10, 2001 Hawaii Chapter Annual Scientific Meeting of the American College of Physicians - American Society of Internal Medicine, Poster Session, Honolulu, Hawaii. Sub-investigator in a WHO Project on “Low Osmolarity Oral Rehydration Solution in Acute Diarrhea in Pediatric Age Group”, at All India Institute of Medical Sciences, New Delhi, India. April 1995-October 1995. RESEARCH
Research on the “Causes of Death in Patients with Dementia”. Presented at the May 9-13, 2001 Annual Scientific Meeting of the American Geriatrics Society, Poster Session, Chicago, Illinois. July 2000- June 2001 Research on “Life Expectancy in Patients with Dementia”. Presented at the February 9-10, 2001 Hawaii Chapter Annual Scientific Meeting of the American College of Physicians - American Society of Internal Medicine, Poster Session, Honolulu, Hawaii. July 2000- June 2001 Research Project On “Recognition of EKG lead misplacements”. Participated at the 1999 New Jersey Chapter Annual Scientific Meeting of the American College of Physicians, Associates Abstract Competition, New Jersey. August 1998- April 1999 RESEARCH PROTOCOLS - BOND CLINIC 2003-2006 VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 5
A Randomized Multicenter Phase II Study of Gemcitabine/Platinum/Cetuximab vs. Gemcitabine/Platinum as First-Line Treatment for Patients with Advanced/Metastatic Non Small Cell Lung cancer (BMS CA225100) Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC A Randomized, Double-Blind, Placebo Controlled Study to Evaluate AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-Metastatic Breast Cancer (AMG162) Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC A Phase III Randomized Multicenter Study of Cetuximab, Oxaliplatin, 5-Fluorouracil, and Leucovorin vs. Oxaliplatin, 5-Fluorouracil, and Leucovorin in Patients with Previously Treated Metastatic, EGFR-Positive Colorectal Carcinoma (CA225014) Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO; Chun Ho So, MD; Sellas Pecos Coble, DO Research Coordinator: Rhonda Drewel, MA, CCRC A Study to Evaluate the Effectiveness of Aranesp at 300mcg Q3W on Clinical Outcomes in Cancer With Anemia Due to Chemotherapy (20030206) Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO; Chun Ho So, MD; Sellas Pecos Coble, DO Research Coordinator: Rhonda Drewel, MA, CCRC Chemotherapy Administered Every 2 Weeks With or Without a Single Injection of Pegfilgrastim As First- or Second-Line Treatment in Subjects with Locally Advanced or Metastatic Colon Cancer (20020715) Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC A Multicenter, Double-Blind, Placebo-Controlled Study of OraVescent Fentanyl Citrate for the Treatment of Breakthrough Pain in Opioid-Tolerant Cancer Patients Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC
VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 6
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Darbepoetin Alpha Administered Once Every 4 Weeks in the Treatment of Subjects with Anemia of Cancer Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Study of Oral CCI-779 Administered in Combination with Letrozole vs. Letrozole Alone as First Line Hormonal Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer Principal Investigator: Vinay Raja, MD Sub-Investigator: Joseph Bond, DO Research Coordinator: Rhonda Drewel, MA, CCRC “An Open Label, Single-Arm Trial of Patients with Metastatic Colorectal Cancer Receiving Irinotecan, 5-Fluorouracil, and Leucovorin Followed by LEUKINE (Sargramostim), a Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor”. Protocol # 001.0021 Principal Investigator: Joseph C. Bond, DO Sub-investigator: Edward A. Bruns, DO; Cathy E. Bond, DO; Mary K. Bruns,
DO; Gregory V. Maynard, DO; Pecos Coble, DO; Vinay Raja, MD
Research Administrator: Linda Schumacher, RN BSN, CCRC Research Coordinator: Rhonda Drewel MA, CCRC: Linda Schumacher, RN, BSN,
A Phase III Study of Delayed vs. Immediate Second-line Therapy with Docetaxel after Gemcitibine + Carboplatin in Advanced Non-Small Cell Lung Cancer Principal Investigator: Joseph Bond, DO Sub-Investigator: S. Pecos Coble, DO; Mary K. Bruns, DO; Cathy E. Bond, DO;
Research Administrator: Linda Schumacher, RN, BSN, CCRC Research Coordinator: Rhonda Drewel, MA, CCRC; Linda Schumacher, RN, BSN,
An Open-label. Randomized Study to Develop a Screening Tool for Functional Capacity in Anemic Subjects with Nonmyeloid Malignancies Receiving Chemotherapy and NESP 20000220 Principal Investigator: Joseph Bond, DO Sub-Investigators: Gregory V. Maynard, DO; Edward Bruns, DO; S. Pecos
Research Administrator: Linda Schumacher RN, BSN, CCRC
VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 7
Research Coordinator: Rhonda Drewel, MA, CCRC; Linda Schumacher, RN, CCRC Cell Therapeutics Protocol PGT302: CT-2103 vs. Docetaxel for the Salvage Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study Principal Investigator: Joseph C. Bond, DO Sub-Investigators: Edward A. Bruns, DO; Sellas Pecos Coble, DO; Chun So,
Research Coordinator: Rhonda Drewel, MA, CCRC CT-2103/Carboplatin for Patients Newly Diagnosed Stage III or IV Ovarian or Primary Peritoneal Cancer: A Phase 2 Study (PGT201) Principal Investigator: Joseph Bond, DO Sub-Investigators: Sellas Pecos Coble, DO; Edward Bruns, DO; Chun So, MD;
Research Coordinator: Rhonda Drewel, MA, CCRC CT-2103 Single Agent or CT-2103 vs Paclitaxel/Carboplatin for the Treatment of PS=2 Patients with Chemotherapy Naive Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase III Study (PGT303) Principal Investigator: Joseph Bond, DO Sub-Investigators: Chun Ho So, MD; Sellas Pecos Coble, DO; Edward A. Bruns,
Research Coordinator: Rhonda Drewel, MA, CCRC A Phase III, Double-Blind, Multicenter, Randomized Study in Chemonaive Patients with Locally Advanced or Metastatic Pancreatic Cancer to Compare a Combination Therapy of Virulizin plus Gemcitabine versus Placebo plus Gemcitabine; Optional Second-Line Therapy may Include Continuation of Virulizin or Placebo, Alone or in Combination with 5-Fluorouracil Principal Investigator: Joseph Bond, DO Sub-Investigators: Chun Ho So, MD; Sellas Pecos Coble, DO; Edward A. Bruns,
Research Coordinator: Rhonda Drewel, MA, CCRC CA225006: A Phase III Randomized, Open-Label, Multicenter Study of Irinotecan and Cetuximab vs. Irinotecan as Second-Line Treatment in Patients with Metastatic, EGFR-Positive Colorectal Carcinoma Principal Investigator: Joseph Bond, DO Sub-Investigators: Chun Ho So, MD; Sellas Pecos Coble, DO; Edward A. Bruns,
VINAY RAJA, M.D. CURRICULUM VITAE—PAGE 8
Research Coordinator: Rhonda Drewel, MA, CCRC "A Randomized, Multicenter, Open-Label, Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma" Millennium Protocol No. M34102-049-VELCADEä Principal Investigator: Joseph Bond, DO Sub-Investigators: Chun Ho So, MD; Sellas Pecos Coble, DO; Edward A. Bruns,
Research Coordinator: Rhonda Drewel, MA, CCRC A Phase III Trial of Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated with or Resistant to an
Anthracycline and Who Are Taxane Resistant (CA163046)
Principal Investigator: Joseph Bond, DO Sub-Investigator: Vinay Raja, MD; Chun Ho So, MD; Sellas Pecos Coble, DO Research Coordinator: Rhonda Drewel, MA, CCRC Randomized Trial of Patient-Specific Vaccination with Conjugated Follicular Lymphoma-Derived Idiotype (FNHLId1) with Local GM-CSF in First Complete Remission Principal Investigator: Joseph Bond, DO Sub-Investigator: Vinay Raja, MD Research Coordinator: Rhonda Drewel, CCRC
PROFESSIONAL MEMBERSHIPS HONORS AND AWARDS Distinction Awards - Anatomy, Physiology, Biochemistry, Microbiology
PATIENT INFORMATION LEAFLET Please read this leaflet Carefully This leaflet will tell you about Clarityn Allergy Syrup . It should give you all the informationyou need, but if there is anything you do not understand please ask your doctor or yourpharmacist. What is in Clarityn Allergy Syrup ? The syrup contains
Melbourne Sports & Aquatic Center - Site License 2011 Victorian Age Championships - 17/12/2010 to 22/12/2010 Event 177 Girls 12 Years 400 LC Metre IM ================================================================== Name Age Team Seed Finals ================================================================== 1 Stickland, Lushavel 12 FOOTSCRAY 5:25.23 5:18.32 34.51 1:15.18 (40.67